000 01627nam  2200361zi 4500
0019.895593
003CaOODSP
00520240209135304
006m     o  d f      
007cr |||||||||||
008210122e202101##onc     o    f000 0 eng d
020 |a9780660371979
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-312/2021E-PDF
24500|aPriority strategies to optimize testing and screening for COVID-19 in Canada : |breport.
264 1|aOttawa, ON : |bHealth Canada, |cJanuary 2021.
264 4|c©2021
300 |a1 online resource (ii, 27 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Stratégies prioritaires pour optimiser les tests et le dépistage de la COVID-19 au Canada : rapport.
500 |aIssued also in HTML format.
650 0|aCOVID-19 (Disease)|xDiagnosis|zCanada.
650 0|aCOVID-19 Pandemic, 2020-|zCanada|xPrevention.
650 0|aCOVID-19 (Disease)|zCanada|xPrevention.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tStratégies prioritaires pour optimiser les tests et le dépistage de la COVID-19 au Canada : |w(CaOODSP)9.895594
85640|qPDF|s685 KB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H164-312-2021-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/testing-screening-advisory-panel/reports-summaries/priority-strategies.html